DOJ Investigation Into Generic Pharma: You Could Be Next
The U.S. Department of Justice Antitrust Division's investigation into the generic pharmaceutical industry may be expanding.[1] On March 15, 2015, a third generic manufacturer disclosed that it received a subpoena from...To view the full article, register now.
Already a subscriber? Click here to view full article